Insider Selling: ASP Isotopes (NASDAQ:ASPI) CEO Sells $649,969.84 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CEO Paul Elliot Mann sold 83,759 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $7.76, for a total value of $649,969.84. Following the completion of the sale, the chief executive officer owned 9,579,845 shares of the company’s stock, valued at $74,339,597.20. This trade represents a 0.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Paul Elliot Mann also recently made the following trade(s):

• On Tuesday, June 2nd, Paul Elliot Mann sold 83,758 shares of ASP Isotopes stock. The stock was sold at an average price of $8.29, for a total value of $694,353.82.

ASP Isotopes Stock Performance

ASPI opened at $6.71 on Friday. The firm has a market cap of $844.79 million, a PE ratio of -3.23 and a beta of 3.42. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The business has a fifty day simple moving average of $5.54 and a 200-day simple moving average of $5.87. ASP Isotopes Inc. has a fifty-two week low of $3.92 and a fifty-two week high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.28) by $0.06. The business had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Institutional Investors Weigh In On ASP Isotopes

Institutional investors have recently added to or reduced their stakes in the company. State of Wyoming acquired a new stake in ASP Isotopes during the first quarter worth about $29,000. Quantbot Technologies LP acquired a new stake in ASP Isotopes during the third quarter worth about $34,000. BNP Paribas Financial Markets grew its position in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares in the last quarter. Stephens Inc. AR acquired a new stake in ASP Isotopes during the first quarter worth about $44,000. Finally, Broadhurst Jeffrey B acquired a new stake in ASP Isotopes during the first quarter worth about $44,000. 16.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a report on Tuesday, April 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Friday, March 27th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.